CD163 and neoplasm: However, in recent years, scholars have mostly focused their prognosis for patients on the impact of tumor cells or the tumor microenvironment, such as CD47 expression and CD163+ macrophages (29), cytokeratin-19 (CK-19) (30), and tumor-infiltrating platelets (31).